Nimodipine Pharmacokinetic Variability in Various Patient Populations
Abstract Nimodipine has been shown to improve outcomes following aneurysmal subarachnoid hemorrhage. Guidelines recommend that all patients receive a fixed dose of oral nimodipine for 21 days. However, pharmacokinetic studies have suggested variability of nimodipine pharmacokinetics in subarachnoid...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2020-09-01
|
| Series: | Drugs in R&D |
| Online Access: | https://doi.org/10.1007/s40268-020-00322-3 |